ArticleBioengineering & translational medicine2017
Picoliter-volume inkjet printing into planar microdevice reservoirs for low-waste, high-capacity drug loading.
Article in Bioengineering & translational medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed.
- Ink to innovation: Pioneering printing technologies for next-generation drug delivery systems.Drug delivery and translational research · 2026Review
- Inkjet Printing of Drugs into Surface-Embedded Micro-Reservoirs for Drug-Releasing Implants: Influence of Solvent Properties on Deposition Behavior.Journal of functional biomaterials · 2026Article
- Influence of the Volatility of Solvent on the Reproducibility of Droplet Formation in Pharmaceutical Inkjet Printing.Pharmaceutics · 2023Article
- Printing Drugs onto Nails for Effective Treatment of Onychomycosis.Pharmaceutics · 2022Article
- Article
- High diversity droplet microfluidic libraries generated with a commercial liquid spotter.Scientific reports · 2021Article
- Linked optical and gene expression profiling of single cells at high-throughput.Genome biology · 2020Article
- Combinatorial Antimicrobial Susceptibility Testing Enabled by Non-Contact Printing.Micromachines · 2020Article
- Orally ingestible medical devices for gut engineering.Advanced drug delivery reviews · 2020Review
- Editorial: The launch phase ofBioengineering & translational medicine · 2019Article
- Bottom-Up Fabrication of Multilayer Enteric Devices for the Oral Delivery of Peptides.Pharmaceutical research · 2019Article
- Introduction to special issue: Bioengineered Therapeutics. The Next Generation of Drug Development.Bioengineering & translational medicine · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Oral delivery of therapeutics is the preferred route for systemic drug administration due to ease of access and improved patient compliance. However, many therapeutics suffer from low oral bioavailability due to low pH and enzymatic conditions, poor cellular permeability, and low residence time. Microfabrication techniques have been used to create planar, asymmetric microdevices for oral drug delivery to address these limitations. The geometry of these microdevices facilitates prolonged drug exposure with unidirectional release of drug toward gastrointestinal epithelium. While these devices have significantly enhanced drug permeability
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.